| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099868 | Journal of Crohn's and Colitis | 2013 | 11 Pages |
Abstract
F. prausnitzii and its unidentified metabolites in the supernatant are promising candidates in treating IBD, and further research remains necessary to elucidate the safety, efficacy, optimum and mechanism of this bacterium in the clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Xinyun Qiu, Mingming Zhang, Xiaotong Yang, Na Hong, Chenggong Yu,